MOTCO’s Jazz Pharmaceuticals JAZZ Stock Holding History

MOTCO’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-192	Closed	-$31K	–	626
2014 Q3	$31K	Buy	+192	New	+$29.5K	﹤0.01%	327

Other funds holding JAZZ

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

WBC

Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MOTCO's JAZZ Position: Q4 2014 in Review

MOTCO sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2014, closing a stake of 192 shares — an estimated $31K sold.

MOTCO first reported a position in JAZZ in Q3 2014 and held it in 1 quarter. The position peaked at $31K in Q3 2014. 357 funds tracked by Wall St. Rank hold JAZZ as of Q4 2014.

MOTCO reported no remaining Jazz Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
MOTCO sold 192 Jazz Pharmaceuticals shares in Q4 2014, an estimated $31K.
MOTCO first reported a position in Jazz Pharmaceuticals in Q3 2014 and held it in 1 quarter.
MOTCO's Jazz Pharmaceuticals position peaked at $31K in Q3 2014.
357 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2014.

Based on MOTCO's 13F filing for Q4 2014, filed 5 Feb 2015.